Where does Nuevolution A/S rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nuevolution A/S ranks #12,145 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nuevolution A/S hold?

Nuevolution A/S holds 25 US utility patents granted between 2015 and 2024, spanning 12 technology areas.

What is Nuevolution A/S's Innovation Score?

Nuevolution A/S has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Nuevolution A/S's patent grant rate increasing or decreasing?

Nuevolution A/S's recent grant velocity is +78% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nuevolution A/S's patents?

Nuevolution A/S's patents average 51.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nuevolution A/S patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nuevolution A/S

Q: What technology areas does Nuevolution A/S focus on?

Nuevolution A/S's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 17 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 12 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nuevolution ranks #12,145 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 12 technology areas.

#12,145
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 51.5
avg claims per patent: +78%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12145 · Foreign Corporation #12,145 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,145/49,997
PHOTO-FINISH National Coupling
CPC-FOCUS C12N · 12 areas
INNOV-PAR 44.4/100
CLAIMS-DENSE 51.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +78% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Coupling Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Crispr Therapeutics · near

44
NantBio · near

44
National Chain · near

44
Nuevolution A/S · this assignee

44
Sunnybrook Health… · near

44
3D Lighting… · lowest

7

What this shows Nuevolution's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nuevolution's grants concentrate

Nuevolution A/S is a focused PatentsView assignee: 12 CPC subclasses with 68% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2016. By volume, Nuevolution sits between Netzsch Pumpen & Systeme GmbH and NoNO Inc..

Nuevolution's three-year grant acceleration

Nuevolution A/S shows 8 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Netzsch Pumpen &…

25
NKT HV Cables AB

25
Norsk Hydro ASA

25
NP Medical

25
National Coupling

25
Naver Business Pl…

25
Nimbus Lakshmi

25
Nono

25
Nuevolution A/S ◀

25

What this shows Nuevolution holds 25 patents at rank #12,136, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nuevolution

By rank, the assignees closest to #12,136 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Nuevolution's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nuevolution, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Sunnybrook Health Sciences Centre 44 National Chain Company 44 NantBio, Inc. 44 Crispr Therapeutics AG 44

Nuevolution's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nuevolution A/S patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	16.0%
2016	1	4.0%
2017	1	4.0%
2018	2	8.0%
2019	1	4.0%
2020	6	24.0%
2021	2	8.0%
2022	3	12.0%
2023	4	16.0%
2024	1	4.0%

Which technologies does Nuevolution A/S patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 13

C07D - Heterocyclic Compounds 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#12,145

of 49,997 tracked assignees

Innovation Score

44.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nuevolution A/S's patent record in context - here's where to go next.

Nuevolution A/S's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 68% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #12,145 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nuevolution A/S against Netzsch Pumpen & Systeme GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.